Medicinal Products

AMOXICILLIN ARROW LAB 500 mg

Clamoxyl Generic Drug
Therapeutic class: Infectiology - Parasitology
active ingredients: Amoxicillin
laboratory: Arrow Generic

capsule
box of 30
All forms

Indication

They arise from the antibacterial activity and pharmacokinetic characteristics of amoxicillin. They take into account both the clinical studies that gave rise to this drug and its place in the range of antibacterial products currently available.

They are limited to infections due to germs defined as sensitive:

In adults and children:

· In initial treatment of:

o acute pneumonitis,

o superinfections of acute bronchitis and exacerbations of chronic bronchitis,

o ENT infections (otitis, sinusitis, documented angina at beta-hemolytic streptococcus A) and stomatology,

o urinary infections,

o male genital infections and gynecological infections,

o digestive and biliary infections,

o Lyme disease: treatment of the primary phase (chronic erythema migrans) and the primary-secondary phase (chronic erythema migrans associated with general signs: asthenia, headache, fever, arthralgia ...),

· In relay treatment of the injectable route of endocarditis, septicemia,

· As a prophylactic treatment for bacterial endocarditis.

In adults only:

· In combination with another antibiotic (clarithromycin or imidazole) and antisecretory agent, eradication of Helicobacter pylori in adult peptic ulcer disease.

Official recommendations concerning the appropriate use of antibacterials should be taken into account.

Dosage AMOXICILLINE ARROW LAB 500 mg capsule box of 30

They arise from the antibacterial activity and pharmacokinetic characteristics of amoxicillin. They take into account both the clinical studies that gave rise to this drug and its place in the range of antibacterial products currently available.

They are limited to infections due to germs defined as sensitive:

In adults and children:

· In initial treatment of:

o acute pneumonitis,

o superinfections of acute bronchitis and exacerbations of chronic bronchitis,

o ENT infections (otitis, sinusitis, documented angina at beta-hemolytic streptococcus A) and stomatology,

o urinary infections,

o male genital infections and gynecological infections,

o digestive and biliary infections,

o Lyme disease: treatment of the primary phase (chronic erythema migrans) and the primary-secondary phase (chronic erythema migrans associated with general signs: asthenia, headache, fever, arthralgia ...),

· In relay treatment of the injectable route of endocarditis, septicemia,

· As a prophylactic treatment for bacterial endocarditis.

In adults only:

· In combination with another antibiotic (clarithromycin or imidazole) and antisecretory agent, eradication of Helicobacter pylori in adult peptic ulcer disease.

Official recommendations concerning the appropriate use of antibacterials should be taken into account.

Against indications

This medicine MUST NEVER BE USED in case of allergy to antibiotics of the beta-lactam family (penicillins and cephalosporins) or to any of the other ingredients.

This medicine SHOULD NOT BE USED in combination with methotrexate (see section Interactions with other medicinal products and other forms of interaction ).

Adverse effects Amoxicillin Arrow Lab

The classification of adverse reactions used is as follows

· Very common: ≥1 / 10

· Frequent: ≥1 / 100; <1/10

· Uncommon: ≥1 / 1000; <1/100

· Rare: ≥1 / 10000; <1/1000

· Very rare: <1/10000

· Frequency not known: can not be estimated on the basis of available data

Blood and lymphatic system disorders

Very rare: leukopenia, neutropenia, agranulocytosis, thrombocytopenia and reversible haemolytic anemia.

Not known: eosinophilia.

Nervous system disorders

Very rare: convulsions.

Not known: vertigo, headache.

Gastrointestinal disorders

Common: diarrhea, nausea

Uncommon: vomiting.

Very rare: pseudomembranous colitis, hemorrhagic colitis.

Renal and urinary disorders

Not known: acute interstitial nephritis and crystalluria.

Skin and subcutaneous tissue disorders

Common: rash

Uncommon: urticaria and pruritus.

Very rare: erythema multiforme, Stevens Johnson syndrome, Lyell syndrome, bullous or exfoliative dermatitis. These skin manifestations may be more frequent and / or more intense in patients with infectious mononucleosis or evolving lymphoid leukemia. Acute generalized exanthematous pustulosis (see Warnings and precautions for use ).

Infections and infestations

Common: cutaneous and mucosal candidiasis

Immune system disorders

Very rare: anaphylaxis (including anaphylactic shock), serum sickness and hypersensitivity vasculitis (see Warnings and precautions for use section ).

Not known: allergic manifestations, including urticaria, angioedema, respiratory discomfort.

Hepatobiliary disorders

Very rare: hepatitis, cholestatic jaundice.

Not known: moderate and transient increase in serum transaminases (ALT and / or ASAT).

Reporting of suspected adverse reactions

The reporting of suspected adverse reactions after authorization of the drug is important. It allows continuous monitoring of the benefit / risk ratio of the drug. Health professionals declare any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.

Popular Posts

Category Medicinal Products, Next Article